BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 3229310)

  • 21. In vitro activity of the killer toxin from yeast Hansenula mrakii against yeasts and molds.
    Yamamoto T; Uchida K; Hiratani T; Miyazaki T; Yagiu J; Yamaguchi H
    J Antibiot (Tokyo); 1988 Mar; 41(3):398-403. PubMed ID: 3366696
    [No Abstract]   [Full Text] [Related]  

  • 22. Beta gamma-crystallin redux.
    Nat Struct Biol; 1996 Aug; 3(8):651-2. PubMed ID: 8756316
    [No Abstract]   [Full Text] [Related]  

  • 23. [The genosystematics of yeast genera Willopsis zender and Zygowillopsis kudriavzev].
    Naumov GI
    Mol Gen Mikrobiol Virusol; 1987 Feb; (2):3-7. PubMed ID: 3553908
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Killer toxins of certain yeast strains have potential growth inhibitory activity on gram-positive pathogenic bacteria.
    Izgü F; Altinbay D
    Microbios; 1997; 89(358):15-22. PubMed ID: 9218351
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ion channel activity by Pichia membranifaciens killer toxin.
    Santos A; Marquina D
    Yeast; 2004 Jan; 21(2):151-62. PubMed ID: 14755640
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immuno-crossreactivity of an anti-Pichia anomala killer toxin monoclonal antibody with a Williopsis saturnus var. mrakii killer toxin.
    Guyard C; Evrard P; Corbisier-Colson AM; Louvart H; Dei-Cas E; Menozzi FD; Polonelli L; Cailliez J
    Med Mycol; 2001 Oct; 39(5):395-400. PubMed ID: 12054049
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of de novo protein synthesis in the interconversion of glucose transport systems in the yeast Pichia ohmeri.
    Verma RS; Spencer-Martins I; Van Uden N
    Biochim Biophys Acta; 1987 Jun; 900(1):139-44. PubMed ID: 3036221
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New yeast expression platforms based on methylotrophic Hansenula polymorpha and Pichia pastoris and on dimorphic Arxula adeninivorans and Yarrowia lipolytica - a comparison.
    Gellissen G; Kunze G; Gaillardin C; Cregg JM; Berardi E; Veenhuis M; van der Klei I
    FEMS Yeast Res; 2005 Nov; 5(11):1079-96. PubMed ID: 16144775
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reflections on internal images.
    Greenspan NS
    Nat Biotechnol; 1997 Feb; 15(2):123-4. PubMed ID: 9035130
    [No Abstract]   [Full Text] [Related]  

  • 30. Therapeutic potential of yeast killer toxin-like antibodies and mimotopes.
    Magliani W; Conti S; Salati A; Vaccari S; Ravanetti L; Maffei DL; Polonelli L
    FEMS Yeast Res; 2004 Oct; 5(1):11-8. PubMed ID: 15381118
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic potential of antiidiotypic single chain antibodies with yeast killer toxin activity.
    Magliani W; Conti S; de Bernardis F; Gerloni M; Bertolotti D; Mozzoni P; Cassone A; Polonelli L
    Nat Biotechnol; 1997 Feb; 15(2):155-8. PubMed ID: 9035141
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [New species of soil yeasts, Williopsis pratensis].
    Bab'eva IP; Reshetova IS
    Mikrobiologiia; 1979; 48(6):1040-3. PubMed ID: 160978
    [No Abstract]   [Full Text] [Related]  

  • 33. Production of anti-toxin antibodies by immunization with Pichia killer toxin-like antiidiotypic monoclonal antibodies.
    Snyder C; Seguy N; Lafitte S; Guyard C; Polonelli L; Cailliez JC; Grzych JM
    J Eukaryot Microbiol; 1999; 46(5):138S. PubMed ID: 10519290
    [No Abstract]   [Full Text] [Related]  

  • 34. A new killer factor produced by a killer-sensitive yeast strain.
    Woods DR; Ross IW; Hendry DA
    J Gen Microbiol; 1974 Apr; 81(2):285-9. PubMed ID: 4599407
    [No Abstract]   [Full Text] [Related]  

  • 35. Killer anti-idiotypes in the control of fungal infections.
    Magliani W; Conti S; Arseni S; Frazzi R; Salati A; Polonelli L
    Curr Opin Investig Drugs; 2001 Apr; 2(4):477-9. PubMed ID: 11566002
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Killer toxins of clinically important yeasts].
    Ozhovan IM; Arzumanian VG; Basnak'ian IA
    Zh Mikrobiol Epidemiol Immunobiol; 2002; (4):79-83. PubMed ID: 12449706
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Occurrence of killer yeast strains in industrial and clinical yeast isolates.
    Baeza ME; Sanhueza MA; Cifuentes VH
    Biol Res; 2008; 41(2):173-82. PubMed ID: 18949135
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Susceptibility of Pneumocystis carinii to a Pichia anomala killer toxin.
    Séguy N; Aliouat EM; Dei-Cas E; Polonelli L; Camus D; Cailliez JC
    J Eukaryot Microbiol; 1994; 41(5):109S. PubMed ID: 7804202
    [No Abstract]   [Full Text] [Related]  

  • 39. The primary target of the killer toxin from Pichia acaciae is tRNA(Gln).
    Klassen R; Paluszynski JP; Wemhoff S; Pfeiffer A; Fricke J; Meinhardt F
    Mol Microbiol; 2008 Aug; 69(3):681-97. PubMed ID: 18532979
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 'Antibiobodies': antibiotic-like anti-idiotypic antibodies.
    Polonelli L; Conti S; Gerloni M; Magliani W; Castagnola M; Morace G; Chezzi C
    J Med Vet Mycol; 1991; 29(4):235-42. PubMed ID: 1941431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.